Navigation Links
Genomatix wins the 'INDUSTRIEPREIS 2012' in the biotech category at Hannover Messe
Date:4/27/2012

Munich, Germany, April 27th, 2012 - Genomatix is proud to announce that it has been awarded the "INDUSTRIEPREIS 2012" in the biotech category at Hannover Messe, the world's biggest technology trade show. The INDUSTRIEPREIS is awarded in 14 categories to companies for products of a high technological, economic, ecological or social value. Nominees and winners are chosen by a panel of 30 experts including professors and specialized journalists. Genomatix has received the INDUSTRIEPREIS for its data analysis and interpretation platform Genomatix Genome Analyzer (GGA).

"We're really proud to have received this award for a data analysis solution", says Dr. Korbinian Grote, product manager at Genomatix. "Usually the focus on big technology fairs is more on lab equipment providers, in our field the sequencer manufacturers stand out with ever new records of gigabases of DNA data they can produce. But researchers also need solutions to analyze and interpret these data to extract the information from it and generate new biomedical knowledge." "Being appreciated for our data analysis solutions is certainly a big motivation for the whole team to come up with even more innovative ideas on how to deal with the increasing deluge of Next Generation Sequencing data", adds Dr. Martin Seifert, CEO of Genomatix, "getting an award that explicitly rewards products of technological and social value underlines that NGS is quickly moving from a research tool into the broader field of clinical application."


'/>"/>
Contact: Korbinian Grote
grote@genomatix.de
0049-599-7660
Genomatix Software GmbH
Source:Eurekalert  

Page: 1

Related biology news :

1. Genomatix to partner in $41 million European epigenomics consortium
2. Genomatix wins "Most Creative Visualization" award at iDEA Challenge 2011
3. Genomatix, USU and HJF execute a CRADA: Prostate cancer prognostic marker discovery by NGS
4. Eurofins MWG Operon and Genomatix developed most complete human exome array
5. Eurofins MWG Operon and Genomatix launch strategic alliance
6. Genomatix gives a hand in the analysis of Wayne States sequencing projects
7. University of Michigan installs second Genomatix Genome Analyzer
8. MCTP bought Genomatix NextGen Sequencing analysis stations
9. Genomatix gets patent for comparative genomics method
10. CRG buys Genomatix Next Generation Sequencing analysis solution
11. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genomatix wins the 'INDUSTRIEPREIS 2012' in the biotech category at Hannover Messe
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... LONDON , Dec. 7, 2016   Avanade ... most successful Formula One teams in history, exploit biometric ... pit stop performance and maintain the competitive edge against ... in 2016. Avanade has worked with ... a range of biometric data (heart rate, breathing rate, ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... , ... January 17, 2017 ... ... surgeons at the 2016 annual meeting of the North American Spine Society ... for patients in the majority of cases, when PEEK-OPTIMA™ HA Enhanced is ...
(Date:1/17/2017)... ... January 17, 2017 , ... Diagenode, ... recently announced a collaboration with the Heidelberg University Hospital and the German Cancer ... preparation, following the company’s successful launch of its CATS (Capture and Amplification ...
(Date:1/16/2017)... 16, 2017   Valentin A. Pavlov, PhD , ... president and CEO of The Feinstein Institute for ... of how the nervous system regulates the immune system, ... bioelectronic medicine devices to treat disease and injury. ... . The paper examines various studies which ...
(Date:1/14/2017)... ARLINGTON, Va. , Jan. 13, 2017  The ... following statement in response to FDA final guidance ... FDA for its continued leadership in emphasizing the importance ... members are keenly aware of the benefits biosimilars will ... costs.   Yet the portion of the ...
Breaking Biology Technology: